SANUWAVE Health Inc. ( (SNWV) ) has released its Q1 earnings. Here is a breakdown of the information SANUWAVE Health Inc. presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sanuwave Health Inc., a company specializing in next-generation FDA-approved wound care products, has reported its financial results for the first quarter of 2025, showcasing significant growth. The company achieved record Q1 revenues of $9.3 million, marking a 61% increase from the previous year, and a gross margin improvement to 79%. Operating income rose to $1.0 million, a notable increase from a loss in the same quarter last year, driven by strategic efforts to enhance profitability and manage expenses. Despite these positive results, the company reported a net loss of $5.7 million, primarily due to changes in the fair value of derivative liabilities. Sanuwave’s UltraMist® systems sales saw a substantial increase, contributing significantly to the company’s revenue growth. Looking ahead, Sanuwave remains optimistic about its growth trajectory, forecasting a 40-50% revenue increase for the second quarter of 2025 compared to the same period in 2024, and maintaining its full-year revenue guidance. The company is focused on expanding its commercial operations and maintaining profitability as it continues to pursue larger customer engagements.